Dignify Therapeutics is a drug development company based in Research Triangle Park, North Carolina, developing on-demand pharmaceutical therapies that restore voluntary bladder and bowel control in people with neurological conditions such as spinal cord injury, multiple sclerosis, spina bifida and stroke. Its lead program targets urinary retention in spinal cord injury, aiming to replace or reduce catheter use. The company has been backed by RA Capital Management, Eshelman Ventures, the North Carolina Biotechnology Center and federal research grants.
1
Round
1
Industry
3
Tags
Sep 25, 2026
Latest raise
Funding activity · 1 round
Sep 25, 2026
$800,000
Debt
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
